Can a natural fatty acid boost gut healing in Crohn's?
NCT ID NCT07417696
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding palmitoleic acid (a natural fatty acid) to the standard drug infliximab helps heal the gut lining better than infliximab alone in people with Crohn's disease. About 400 adults with active Crohn's will take part. The main goal is to see if the combination leads to complete healing of intestinal ulcers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two-Drug cocktail aims to tame stubborn Crohn's disease
- Could Two-Drug cocktails tame stubborn inflammatory bowel disease?
- Could stopping acid reflux drugs improve IBD treatment?
- Placenta cells could tame Crohn's inflammation
- New daily pill aims to tame Crohn's Flare-Ups
- New oral pill H021 aims to tame Crohn's Flare-Ups